Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

Campy CVA Medium 100/PK, R01272

FDA Recall Z-1474-2026 · Posted 2026-02-26

Recalling FirmRemel, Inc
Recall StatusOpen, Classified
Product CodeJSJ
Date Initiated2026-02-05
Product Quantity97

Reason for Recall

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

Firm Action

On February 5, 2026, the firm notified affected customers via Urgent Medical Device Recall letter. Customers were instructed to review test results and destroy any remaining inventory of the affected lot.

Root Cause

Under Investigation by firm

Distribution Pattern

US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑